Literature DB >> 11154739

Sulfotransferases in the bioactivation of xenobiotics.

H Glatt1.   

Abstract

Conjugation of xenobiotics is often associated with detoxification. However, this traditional view is one-sided. In particular, numerous compounds are known that are metabolized to chemically reactive metabolites via sulfation (O-sulfonation). This can be rationalized by the fact that the sulfate group is electron-withdrawing and may be cleaved off heterolytically in appropriate molecules, thus leading to the formation of a strongly electrophilic cation. The heterologous expression of sulfotransferases in indicator cells of standard mutagenicity tests has substantially improved the accessibility of this activation pathway. The use of this technology is important, since many reactive sulfate conjugates only show strong toxicological effects if they are generated directly within the indicator cell, due to their insufficient penetration of cell membranes. Xenobiotic-metabolizing sulfotransferases are cytosolic enzymes, which form a superfamily (SULT). Eleven distinct human SULT forms are known, which strongly differ in their tissue distribution and their substrate specificity. Common functionally relevant genetic polymorphisms of the transcribed region are known for two of the forms, SULT1A1 and 1A2. Studies using recombinant test systems demonstrate that many promutagens are activated with high selectivity by an individual SULT form. Pronounced differences in promutagen activation were detected between the different human forms, including their allelic variants, and also between orthologous SULTs from different species. Therefore, SULTs may be involved in the individual genetic disposition, species differences, and organotropisms for toxicological effects of chemicals. Activation by SULTs differs from other activation pathway in its cyclic nature: reaction of a sulfuric acid ester with water usually regenerates the hydroxylated compound, which becomes available for a new cycle of activation. SULT-mediated reactivation may even occur if another initial reactive species, e.g. an epoxide, has reacted with water.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11154739     DOI: 10.1016/s0009-2797(00)00202-7

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  65 in total

1.  Oxidative modification of rat sulfotransferase 1A1 activity in hepatic tissue slices correlates with effects on the purified enzyme.

Authors:  Jagadeesha K Dammanahalli; Michael W Duffel
Journal:  Drug Metab Dispos       Date:  2011-10-31       Impact factor: 3.922

Review 2.  Contributions of human enzymes in carcinogen metabolism.

Authors:  Slobodan Rendic; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-05-10       Impact factor: 3.739

3.  The human estrogen sulfotransferase: a half-site reactive enzyme.

Authors:  Meihao Sun; Thomas S Leyh
Journal:  Biochemistry       Date:  2010-06-15       Impact factor: 3.162

4.  A high frequency missense SULT1B1 allelic variant (L145V) selectively expressed in African descendants exhibits altered kinetic properties.

Authors:  Zachary E Tibbs; Amber L Guidry; Josie L Falany; Susan A Kadlubar; Charles N Falany
Journal:  Xenobiotica       Date:  2017-02-05       Impact factor: 1.908

5.  Substrate inhibition in human hydroxysteroid sulfotransferase SULT2A1: studies on the formation of catalytically non-productive enzyme complexes.

Authors:  Hayrettin Ozan Gulcan; Michael W Duffel
Journal:  Arch Biochem Biophys       Date:  2010-12-25       Impact factor: 4.013

6.  Identification of sulfation sites of metabolites and prediction of the compounds' biological effects.

Authors:  Lin Yi; Joe Dratter; Chao Wang; Jon A Tunge; Heather Desaire
Journal:  Anal Bioanal Chem       Date:  2006-05-25       Impact factor: 4.142

7.  RNA-sequencing quantification of hepatic ontogeny and tissue distribution of mRNAs of phase II enzymes in mice.

Authors:  Hong Lu; Sumedha Gunewardena; Julia Y Cui; Byunggil Yoo; Xiao-bo Zhong; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2013-02-04       Impact factor: 3.922

8.  Pharmacogenetics of SULT1A1.

Authors:  Jaclyn Daniels; Susan Kadlubar
Journal:  Pharmacogenomics       Date:  2014-11       Impact factor: 2.533

9.  Inhibition of human phenol and estrogen sulfotransferase by certain non-steroidal anti-inflammatory agents.

Authors:  Roberta S King; Anasuya A Ghosh; Jinfang Wu
Journal:  Curr Drug Metab       Date:  2006-10       Impact factor: 3.731

10.  The gate that governs sulfotransferase selectivity.

Authors:  Ian Cook; Ting Wang; Steven C Almo; Jungwook Kim; Charles N Falany; Thomas S Leyh
Journal:  Biochemistry       Date:  2012-12-28       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.